What is Morgan Scientific?
Morgan Scientific specializes in providing a comprehensive suite of pulmonary function testing equipment, encompassing spirometers, body boxes, and advanced software solutions such as ComPAS2. The company serves a diverse clientele, including pediatric hospitals, clinical research facilities, academic institutions, and private pulmonology practices. Their product philosophy centers on delivering reliable, accurate, and user-friendly diagnostic tools. Morgan Scientific actively engages with its customer base to guide product development, ensuring their innovations align with evolving clinical and financial requirements. This customer-centric approach, coupled with a dedication to superior service and cutting-edge solutions, positions Morgan Scientific as a key player in enhancing the efficiency and effectiveness of pulmonary diagnostics.
How much funding has Morgan Scientific raised?
Morgan Scientific has raised a total of $760K across 2 funding rounds:
Debt
$350K
Debt
$410K
Debt (2020): $350K with participation from PPP
Debt (2021): $410K led by PPP
What's next for Morgan Scientific?
The recent major strategic investment signals a pivotal moment for Morgan Scientific, likely enabling accelerated expansion of its product development pipeline and market reach. This influx of capital is expected to fuel further innovation in pulmonary diagnostics, potentially leading to the introduction of next-generation testing equipment and software. The company's focus on collaboration and customer-driven development suggests that future offerings will continue to address specific needs within clinical and research settings. This strategic financing round positions Morgan Scientific to solidify its leadership in the pulmonary function testing market and capitalize on emerging opportunities in healthcare technology.
See full Morgan Scientific company page
